Skip to Main Content

Paper Details

Homogeneous antibody-angiopep 2 conjugates for effective brain targeting.
RSC Adv
4
2022
Author NameAffiliation
Chisato YamasakiTexas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Center at Houston Houston Texas 77054 USA Zhiqiang.An@uth.tmc.edu Ningyan.Zhang@uth.tmc.edu Chisato.Tsuchikama@uth.tmc.edu Aiko.Yamaguchi@uth.tmc.edu.
Ningyan ZhangTexas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Center at Houston Houston Texas 77054 USA Zhiqiang.An@uth.tmc.edu Ningyan.Zhang@uth.tmc.edu Chisato.Tsuchikama@uth.tmc.edu Aiko.Yamaguchi@uth.tmc.edu.
Zhiqiang AnTexas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Center at Houston Houston Texas 77054 USA Zhiqiang.An@uth.tmc.edu Ningyan.Zhang@uth.tmc.edu Chisato.Tsuchikama@uth.tmc.edu Aiko.Yamaguchi@uth.tmc.edu.
  • 1 - 3

Datasets